Mary Cushman/X
Oct 12, 2025, 11:28
Is it time for GLP1 receptor agonists in VTE care?
Mary Cushman, Hematologist, University Distinguished Professor and Vice Chair for Emerging Researchers at UVM Department of Medicine, posted on X:
”Is it time for GLP1 receptor agonists in VTE care?
– In people with BMI >30, GLP-1 RA associated w/ 27% lower risk of venous thrombosis compared to use of other obesity reducing meds.
– Data from EHRs of 140 institutions.
– Target trial design.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 11:16Ocima Richard Draza: Postpartum Hemorrhage – A Practical Step-by-Step Management Guide
-
Jun 1, 2026, 10:57Kyungjun Lim: How Will Future Mars Colonies Manage Their Supply Chains?
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership